普昂医疗
(920069)
| 流通市值：5.58亿 | | | 总市值：16.89亿 |
| 流通股本：1748.95万 | | | 总股本：5291.98万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 349,532,909.33 | 223,178,034.96 | 99,307,104.37 | 382,193,622.56 |
| 营业总成本 | 257,387,853.91 | 164,816,534.87 | 73,165,861.63 | 286,279,519.41 |
| 其他经营收益 | | | | |
| 营业利润 | 96,412,051.92 | 60,452,001.98 | 27,816,515.64 | 104,851,478.39 |
| 利润总额 | 97,716,984.01 | 61,909,076.83 | 27,785,768.73 | 103,438,057.16 |
| 净利润 | 84,603,321.57 | 53,139,178.38 | 23,664,220.49 | 89,775,785.62 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 84,603,321.57 | 53,139,178.38 | 23,664,220.49 | 89,775,785.62 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 364,576,913.55 | 359,025,360.43 | 377,280,630.23 | 206,491,287.61 |
| 非流动资产: | | | | |
| 非流动资产合计 | 578,482,824.05 | 553,048,543.92 | 541,207,367.6 | 539,905,107.85 |
| 资产总计 | 943,059,737.6 | 912,073,904.35 | 918,487,997.83 | 746,396,395.46 |
| 流动负债: | | | | |
| 流动负债合计 | 85,899,435.23 | 85,415,206.63 | 82,089,176.17 | 94,168,667.2 |
| 非流动负债: | | | | |
| 非流动负债合计 | 30,809,653.11 | 32,272,273.67 | 44,858,303.93 | 50,477,132.4 |
| 负债合计 | 116,709,088.34 | 117,687,480.3 | 126,947,480.1 | 144,645,799.6 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 826,350,649.26 | 794,386,424.05 | 791,540,517.73 | 601,750,595.86 |
| 股东权益合计 | 826,350,649.26 | 794,386,424.05 | 791,540,517.73 | 601,750,595.86 |
| 负债和股东权益合计 | 943,059,737.6 | 912,073,904.35 | 918,487,997.83 | 746,396,395.46 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 369,313,780.7 | 234,729,428.05 | 116,763,644.63 | 416,507,453.63 |
| 经营活动现金流出小计 | 269,397,871.92 | 170,581,723.07 | 89,347,459.21 | 301,235,937.33 |
| 经营活动产生的现金流量净额 | 99,915,908.78 | 64,147,704.98 | 27,416,185.42 | 115,271,516.3 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 164,744,610.81 | 65,222,312.93 | - | 472,300 |
| 投资活动现金流出小计 | 314,160,349.67 | 180,891,961.33 | 20,804,235.19 | 63,238,809.28 |
| 投资活动产生的现金流量净额 | -149,415,738.86 | -115,669,648.4 | -20,804,235.19 | -62,766,509.28 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 194,639,672.04 | 194,511,864 | 194,511,864 | 15,000,000 |
| 筹资活动现金流出小计 | 71,430,156.5 | 71,430,156.5 | 22,906,634.92 | 92,378,068.44 |
| 筹资活动产生的现金流量净额 | 123,209,515.54 | 123,081,707.5 | 171,605,229.08 | -77,378,068.44 |
| 汇率变动对现金及现金等价物的影响 | -4,633,670.75 | -3,357,531.11 | -1,538,333.96 | 653,228.1 |
| 现金及现金等价物净增加额 | 69,076,014.71 | 68,202,232.97 | 176,678,845.35 | -24,219,833.32 |
| 期末现金及现金等价物余额 | 102,989,820.07 | 102,116,038.33 | 210,592,650.71 | 33,913,805.36 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 68,202,232.97 | - | -24,219,833.32 |